---
schema_version: "secwatch.filing_event.v1"
accession: "0001759655-22-000083"
form_type: "8-K"
ticker: "PRVA"
cik: "0001759655"
company_name: "Privia Health Group, Inc."
filed_at: "2022-07-01T23:59:59+00:00"
generated_at: "2026-06-24T21:45:14.853653+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Privia Health reaffirms FY2022 adjusted EBITDA guidance of $52M-$56M

## Summary
- Reiterates full-year 2022 adjusted EBITDA range of $52M-$56M, representing 25.6%-35.3% growth over prior year.
- Expects approximately 90% of adjusted EBITDA to convert to free cash flow.
- No reconciliation provided for non-GAAP forward-looking measures; GAAP equivalents not forecastable without unreasonable effort.
- Guidance subject to risks outlined in annual report and other SEC filings.

## SEC filing metadata
- accession: 0001759655-22-000083
- form_type: 8-K
- ticker: PRVA
- cik: 0001759655
- company_name: Privia Health Group, Inc.
- filed_at: 2022-07-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759655/000175965522000083/0001759655-22-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759655/000175965522000083/prva-20220701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001759655-22-000083
- JSON: https://secwatch.observer/filing/0001759655-22-000083.json
- Plain text: https://secwatch.observer/filing/0001759655-22-000083.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.